Treatment offers hope for young patients struggling with severe hair loss
Baricitinib Restores Hair Growth in Adolescents With Severe Alopecia Areata
Topline:
A phase 3 clinical trial demonstrated that the JAK inhibitor baricitinib significantly improved hair growth in adolescents with severe alopecia areata, with some achieving a 90% reduction in hair loss over 36 weeks.
Study Details
Alopecia areata (AA) is an autoimmune disorder that leads to unpredictable hair loss, significantly affecting the qual…



